Goldenwell BiotechGWLL 30 EBIT per Share is $-0.00 as of Mar. 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,581 Consumer Packaged Goods companies, Goldenwell Biotech ranks better than 88.55% on this metric.
Goldenwell Biotech's EBIT per Share for the
three
months ended in Mar. 2026 was $0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.00.
During the past 3 years, the average EBIT per Share Growth Rate was 53.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Goldenwell Biotech's EBIT per Share or its related term are showing as below:
GWLL'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 0 Med: 26.8 Max: 53.6
Current: 53.6
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Goldenwell Biotech was 53.60% per year. The lowest was 0.00% per year. And the median was 26.80% per year.
GWLL's 3-Year EBIT Growth Rate is ranked better than 88.55% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs GWLL: 53.60
Goldenwell Biotech (OTCPK:GWLL) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Goldenwell Biotech EBIT per Share Related Terms
Goldenwell Biotech EBIT per Share Historical Data
* Premium members only.
The historical data trend for Goldenwell Biotech's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Goldenwell Biotech (GWLL) has a EBIT per Share of $-0.00 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Goldenwell Biotech and its competitors. According to the industry distribution chart, Goldenwell Biotech ranks #181 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 11.4%.
Is Goldenwell Biotech's EBIT per Share too high?
Goldenwell Biotech's current EBIT per Share is $-0.00. Based on the distribution chart, Goldenwell Biotech ranks #181 out of 1581 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's EBIT per Share compare to HAIN and LSF?
According to the Consumer Packaged Goods industry distribution chart, Goldenwell Biotech ranks #181 out of 1581 companies for EBIT per Share. This places Goldenwell Biotech in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Goldenwell Biotech and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Goldenwell Biotech's current EBIT per Share is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current EBIT per Share of $-0.00. The current EBIT per Share is $-0.00. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current EBIT per Share is $-0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score
Get the complete analysis for GWLL
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWLL has been successfully added to your 
